(MMS) Maximus - Ratings and Ratios
Business Process Services, Eligibility & Enrollment, Customer Contact Centers, Health & Disability Assessments, Technology
MMS EPS (Earnings per Share)
MMS Revenue
Description: MMS Maximus November 07, 2025
Maximus, Inc. (NYSE:MMS) is a global provider of outsourced government services organized into three segments: U.S. Federal Services, U.S. Services, and Outside the U.S. The Federal Services arm delivers business-process outsourcing, eligibility and enrollment, clinical and technology solutions-including advanced analytics, cybersecurity, and cloud modernization-for federal health and human-services programs. The U.S. Services segment focuses on multi-channel enrollment support, beneficiary outreach, and a suite of employment-service offerings such as case management and job-readiness programs. The Outside the U.S. segment extends similar business-process and technology solutions to international governments, covering health assessments, employment-service administration, and digital customer-service platforms.
Key recent metrics underline the company’s growth trajectory: FY 2023 revenue reached approximately $5.2 billion, up 8 % year-over-year, driven largely by expanding Medicaid and unemployment-benefits contracts; the operating margin held steady near 9 %, reflecting disciplined cost management amid higher labor costs. The backlog of signed contracts-estimated at $13 billion-provides a multi-year revenue runway, while FY 2024 guidance anticipates double-digit top-line growth, supported by increased federal spending on health-care modernization and state-level workforce-development initiatives. Macro-level, the sector benefits from a sustained policy trend toward outsourcing non-core government functions and from demographic pressures that raise demand for health-service eligibility processing.
For a deeper, data-driven view of Maximus’s valuation dynamics and scenario analysis, you may find the research tools on ValueRay worth exploring.
MMS Stock Overview
| Market Cap in USD | 4,684m |
| Sub-Industry | Data Processing & Outsourced Services |
| IPO / Inception | 1997-06-12 |
MMS Stock Ratings
| Growth Rating | 37.3% |
| Fundamental | 65.5% |
| Dividend Rating | 51.0% |
| Return 12m vs S&P 500 | -16.6% |
| Analyst Rating | 4.0 of 5 |
MMS Dividends
| Dividend Yield 12m | 1.78% |
| Yield on Cost 5y | 2.19% |
| Annual Growth 5y | 1.74% |
| Payout Consistency | 96.9% |
| Payout Ratio | 20.8% |
MMS Growth Ratios
| Growth Correlation 3m | -18.2% |
| Growth Correlation 12m | 43.2% |
| Growth Correlation 5y | 19.3% |
| CAGR 5y | 12.12% |
| CAGR/Max DD 3y (Calmar Ratio) | 0.40 |
| CAGR/Mean DD 3y (Pain Ratio) | 1.35 |
| Sharpe Ratio 12m | -0.24 |
| Alpha | -15.30 |
| Beta | 0.567 |
| Volatility | 24.91% |
| Current Volume | 439.4k |
| Average Volume 20d | 439.4k |
| Stop Loss | 81.5 (-3.1%) |
| Signal | 0.62 |
Piotroski VR‑10 (Strict, 0-10) 4.5
| Net Income (316.2m TTM) > 0 and > 6% of Revenue (6% = 325.7m TTM) |
| FCFTA -0.03 (>2.0%) and ΔFCFTA -12.32pp (YES ≥ +1.0pp, WARN ≥ +0.5pp) |
| NWC/Revenue 16.56% (prev 7.59%; Δ 8.97pp) (YES ≤20% & Δ≤-1pp; WARN ≤25% & Δ≤0 oder ≤40% & Δ≤-3pp) |
| CFO/TA -0.01 (>3.0%) and CFO -56.2m <= Net Income 316.2m (YES >=105%, WARN >=100%) |
| Net Debt (1.72b) to EBITDA (648.1m) ratio: 2.66 <= 3.0 (WARN <= 3.5) |
| Current Ratio 2.27 (target 1.5–3.0; WARN 1.2–<1.5 or >3.0–5.0; CFO/TA gate active) |
| Outstanding Shares last Quarter (57.0m) change vs 12m ago -7.16% (target <= -2.0% for YES) |
| Gross Margin 23.98% (prev 23.22%; Δ 0.75pp) >=18% & Δ>=+0.5pp (WARN >=15% & Δ>=0) |
| Asset Turnover 128.3% (prev 131.3%; Δ -2.96pp) >=50% & Δ>=+2pp (WARN >=35% & Δ>=0) |
| Interest Coverage Ratio 6.35 (EBITDA TTM 648.1m / Interest Expense TTM 81.7m) >= 6 (WARN >= 3) |
Altman Z'' 3.68
| (A) 0.20 = (Total Current Assets 1.61b - Total Current Liabilities 706.2m) / Total Assets 4.46b |
| (B) 0.26 = Retained Earnings (Balance) 1.16b / Total Assets 4.46b |
| (C) 0.12 = EBIT TTM 518.7m / Avg Total Assets 4.23b |
| (D) 0.66 = Book Value of Equity 1.77b / Total Liabilities 2.69b |
| Total Rating: 3.68 = (6.56 * A) + (3.26 * B) + (6.72 * C) + (1.05 * D) |
ValueRay F-Score (Strict, 0-100) 65.51
| 1. Piotroski 4.50pt = -0.50 |
| 2. FCF Yield -2.25% = -1.12 |
| 3. FCF Margin -2.65% = -0.99 |
| 4. Debt/Equity 1.00 = 2.02 |
| 5. Debt/Ebitda 2.66 = -1.23 |
| 6. ROIC - WACC (= 6.08)% = 7.60 |
| 7. RoE 18.25% = 1.52 |
| 8. Rev. Trend 86.98% = 6.52 |
| 9. EPS Trend 33.88% = 1.69 |
What is the price of MMS shares?
Over the past week, the price has changed by +1.15%, over one month by -6.82%, over three months by +7.76% and over the past year by -4.93%.
Is Maximus a good stock to buy?
Based on momentum, paid dividends and discounted-cash-flow analyses, the fair value of MMS is around 79.55 USD . This means that MMS is currently overvalued and has a potential downside of -5.39%.
Is MMS a buy, sell or hold?
- Strong Buy: 0
- Buy: 2
- Hold: 0
- Sell: 0
- Strong Sell: 0
What are the forecasts/targets for the MMS price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 105 | 24.9% |
| Analysts Target Price | 105 | 24.9% |
| ValueRay Target Price | 86.8 | 3.3% |
MMS Fundamental Data Overview November 04, 2025
P/E Trailing = 15.4498
P/E Forward = 18.2482
P/S = 0.8628
P/B = 2.9001
P/EG = 2.0716
Beta = 0.567
Revenue TTM = 5.43b USD
EBIT TTM = 518.7m USD
EBITDA TTM = 648.1m USD
Long Term Debt = 1.61b USD (from longTermDebt, last quarter)
Short Term Debt = 88.1m USD (from shortTermDebt, last quarter)
Debt = 1.78b USD (from shortLongTermDebtTotal, last quarter)
Net Debt = 1.72b USD (from netDebt column, last quarter)
Enterprise Value = 6.40b USD (4.68b + Debt 1.78b - CCE 59.8m)
Interest Coverage Ratio = 6.35 (Ebit TTM 518.7m / Interest Expense TTM 81.7m)
FCF Yield = -2.25% (FCF TTM -143.8m / Enterprise Value 6.40b)
FCF Margin = -2.65% (FCF TTM -143.8m / Revenue TTM 5.43b)
Net Margin = 5.83% (Net Income TTM 316.2m / Revenue TTM 5.43b)
Gross Margin = 23.98% ((Revenue TTM 5.43b - Cost of Revenue TTM 4.13b) / Revenue TTM)
Gross Margin QoQ = 26.66% (prev 24.88%)
Tobins Q-Ratio = 1.44 (Enterprise Value 6.40b / Total Assets 4.46b)
Interest Expense / Debt = 1.27% (Interest Expense 22.7m / Debt 1.78b)
Taxrate = 25.87% (37.0m / 143.0m)
NOPAT = 384.5m (EBIT 518.7m * (1 - 25.87%))
Current Ratio = 2.27 (Total Current Assets 1.61b / Total Current Liabilities 706.2m)
Debt / Equity = 1.00 (Debt 1.78b / totalStockholderEquity, last quarter 1.77b)
Debt / EBITDA = 2.66 (Net Debt 1.72b / EBITDA 648.1m)
Debt / FCF = -11.97 (negative FCF - burning cash) (Net Debt 1.72b / FCF TTM -143.8m)
Total Stockholder Equity = 1.73b (last 4 quarters mean from totalStockholderEquity)
RoA = 7.09% (Net Income 316.2m / Total Assets 4.46b)
RoE = 18.25% (Net Income TTM 316.2m / Total Stockholder Equity 1.73b)
RoCE = 15.52% (EBIT 518.7m / Capital Employed (Equity 1.73b + L.T.Debt 1.61b))
RoIC = 12.21% (NOPAT 384.5m / Invested Capital 3.15b)
WACC = 6.13% (E(4.68b)/V(6.46b) * Re(8.10%) + D(1.78b)/V(6.46b) * Rd(1.27%) * (1-Tc(0.26)))
Discount Rate = 8.10% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: -100.0 | Cagr: -3.77%
Fair Price DCF = unknown (Cash Flow -143.8m)
EPS Correlation: 33.88 | EPS CAGR: -49.46% | SUE: -4.0 | # QB: 0
Revenue Correlation: 86.98 | Revenue CAGR: 5.07% | SUE: 0.75 | # QB: 0
Additional Sources for MMS Stock
Tweets: X | Stocktwits
Fund Manager Positions: Dataroma | Stockcircle